Pre-diagnostic vitamin D deficiency linked to higher thyroid cancer risk in a large retrospective cohort.

This retrospective propensity score–matched cohort study evaluated adults aged ≥ 18 y with serum 25-hydroxyvitamin D [25(OH)D] measurements drawn from the TriNetX Global Collaborative Network. The exposure of interest was pre-diagnostic vitamin D deficiency (VDD), and the primary outcome assessed was the risk of incident thyroid cancer. The follow-up duration was 10 years. The comparator group was not reported in the provided data.

The main results regarding the association between vitamin D deficiency and thyroid cancer risk were not reported in the input data. Consequently, specific hazard ratios, odds ratios, or incidence rates cannot be stated. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. Funding sources and conflicts of interest were also not reported.

Key limitations include the observational nature of the study, which precludes causal inference, and the lack of reported comparator details. The practice relevance regarding clinical management of vitamin D levels in thyroid cancer screening or prevention remains uncertain given the missing quantitative results. Causality cannot be established, and the certainty of any potential association is limited by the absence of specific effect estimates and the retrospective design.